<DOC>
	<DOCNO>NCT00298844</DOCNO>
	<brief_summary>The study aim establish consecutive population newly refer type 2 diabetes mellitus patient among describe degree macrovascular disease evaluate leave ventricular systolic diastolic function ( echocardiography ) , myocardial perfusion ( single-photon emission compute tomography ( SPECT ) ) , peripheral vascular perfusion ( strain gauge toe blood pressure measurement ultrasound scan a. carotis communis ) . Further , degree microvascular disease evaluate ( glomerular filtration rate assessment , fundus photography biotesiometry ) . Finally cohort follow next two year assess prognostic value above-mentioned parameter</brief_summary>
	<brief_title>Prevalence Macrovascular Disease Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age : â‰¥ 20 year . Fasting Cpeptide &gt; 300 pmol/l . Verified medical history macrovascular disease ( stroke , myocardiac infarct , coronary revascularisation strain gauge toe blood pressure &lt; 30 mmHg ) . Suspected short lifespan malignant disease endstage kidney disease . Pregnancy plan pregnancy study period . Body weight &gt; 150 kg . Physical mental disability enable participation study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Macrovascular disease</keyword>
	<keyword>Diastolic dysfunction</keyword>
	<keyword>Intima medium thickness</keyword>
	<keyword>Single- photon emission compute tomography ( SPECT )</keyword>
</DOC>